WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) Stock Short Interest Jumps 71.6%

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) was the recipient of a significant increase in short interest in September. As of September 30th, there was short interest totaling 38,536 shares, an increase of 71.6% from the September 15th total of 22,457 shares. Based on an average daily volume of 204,785 shares, the days-to-cover ratio is presently 0.2 days. Currently, 0.0% of the shares of the stock are sold short.

Analyst Ratings Changes

Separately, Zacks Research upgraded shares of WuXi Biologics (Cayman) to a “hold” rating in a research report on Friday, August 28th. One equities research analyst has rated the stock with a Hold rating. According to MarketBeat.com, the stock has an average rating of “Hold”.

WuXi Biologics (Cayman) Stock Performance

Shares of WXXWY opened at $12.50 on Friday. The business has a fifty day moving average of $12.88 and a 200 day moving average of $10.27. WuXi Biologics has a 52-week low of $7.30 and a 52-week high of $14.80.

WuXi Biologics (Cayman) Company Profile

WuXi Biologics (Cayman) Inc is a global contract research, development and manufacturing organization (CRDMO) focused on biologic medicines. The company works with pharmaceutical and biotechnology customers to support the development and production of biologic therapies, including monoclonal antibodies, recombinant proteins, vaccines and other complex biological products.

Its services span early-stage discovery and cell-line development through process development, clinical manufacturing, regulatory support and commercial-scale production.